Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Denial of Patient's Test Requests Affects Patient Satisfaction

Denial of Patient's Test Requests Affects Patient Satisfaction

By

Patient satisfaction was reportedly worse with clinicians denying certain requests, including laboratory test, referrals, pain medications, and other tests.

Zilretta Now Available for Osteoarthritis Knee Pain

Zilretta Now Available for Osteoarthritis Knee Pain

By

Flexion Therapeutics announced the availability of Zilretta (triamcinolone acetonide extended-release injectable suspension) indicated for the management of pain associated with osteoarthritis (OA) of the knee.

FDA Grants Priority Review to Lofexidine for Management of Opioid Withdrawal Symptoms

FDA Grants Priority Review to Lofexidine for Management of Opioid Withdrawal Symptoms

By

US WorldMeds announced that the Food and Drug Administration has accepted for Priority Review the New Drug Application for lofexidine to manage the symptoms associated with opioid withdrawal and to facilitate completion of opioid discontinuation treatment.

FDA Expresses Safety Concern Over Kratom

FDA Expresses Safety Concern Over Kratom

By

The Food and Drug Administration's Commissioner Scott Gottlieb, MD, has issued a statement regarding the deadly risks associated with the botanical substance, kratom.

Zecuity Acute Migraine Patch No Longer Available

Zecuity Acute Migraine Patch No Longer Available

By

The FDA has posted a discontinuation notice for Zecuity, an iontophoretic transdermal system for the treatment for acute migraine in adults.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-Newsletters